Gastroparesis is uncommon but not extremely rare. Out of every 100,000 people, roughly 10 men and 40 women have the condition. The National Organization for Rare Disorders does include gastroparesis in its database, and the National Institute of Diabetes and Digestive and Kidney Diseases describes it as “not common.” However, the true number of people living with gastroparesis is likely higher than official figures suggest, because misdiagnosis is widespread.
How Common Is Gastroparesis, Really?
The prevalence numbers (10 per 100,000 men, 40 per 100,000 women) come from confirmed diagnoses, but those figures probably undercount the actual burden. A retrospective review at Mayo Clinic Florida looked at 339 patients referred for gastroparesis evaluation and found that only about 20% actually had the condition after proper testing. The other 80% received alternative diagnoses, most commonly functional dyspepsia, a condition that causes similar symptoms but involves different underlying problems. This cuts both ways: many people told they have gastroparesis don’t, and many people with genuine delayed stomach emptying may be walking around with a different label entirely.
The diagnostic process itself creates a bottleneck. Gastroparesis is confirmed through a gastric emptying study, where you eat a standardized meal containing a small amount of radioactive tracer and then sit for four hours of imaging. If more than 10% of the meal remains in your stomach at the four-hour mark, that supports a diagnosis of delayed gastric emptying. Not every doctor orders this test for patients with chronic nausea and bloating, which means some cases go undetected for years.
Why Women Are Affected Far More Often
Gastroparesis disproportionately affects women, who account for roughly 76% of hospitalizations related to the condition. This gender gap isn’t present in early childhood. Up to age five, girls and boys are hospitalized at nearly equal rates. But starting around age 12, the female share of cases rises sharply, climbing to about 77% by the teenage years and staying elevated into adulthood. The reasons aren’t fully understood, but the timing coincides with puberty, suggesting hormonal factors play a role in how the stomach’s nerve and muscle function develops or breaks down.
The average age at hospitalization is around 46, though gastroparesis can appear at any point in life. The demographics also shift depending on what’s causing the condition, with diabetic gastroparesis and idiopathic (unexplained) gastroparesis affecting somewhat different populations.
What Causes It
The biggest surprise for most people is that more than half of gastroparesis cases have no identifiable cause. These are classified as idiopathic, meaning doctors can confirm the stomach empties too slowly but can’t pinpoint why. The remaining cases break down into a few major categories.
- Diabetes: Long-standing high blood sugar can damage the vagus nerve, which controls stomach contractions. This is the most well-known cause, but it’s not the most common one.
- Post-surgical: Certain abdominal or chest surgeries can inadvertently damage nerves that regulate stomach emptying.
- Post-viral: Some people develop gastroparesis after a severe viral infection. The virus triggers inflammation that damages the stomach’s nerve signaling, and in some cases, the damage doesn’t fully heal.
Post-viral gastroparesis has drawn renewed attention since the COVID-19 pandemic. Case reports document patients developing delayed gastric emptying as part of long COVID, and early evidence suggests this may be increasing the overall number of idiopathic cases. Post-viral gastroparesis existed before COVID, but the sheer number of infections worldwide appears to be making it more visible.
What Gastroparesis Feels Like
The hallmark experience is feeling full long before you’ve eaten a normal amount, or feeling uncomfortably full hours after a meal. In studies of patients with confirmed gastroparesis, the most frequently reported symptoms are a persistent sense of fullness (about 45% of patients), nausea (41%), bloating (40%), and early satiety (37%). Vomiting, which many people assume is the defining symptom, actually occurs in only about 15% of patients. Retching without vomiting is more common, reported by roughly 26%.
Many people describe the feeling as food “sitting like a brick” in their stomach. Abdominal pain is also common, though it varies widely in intensity. Some people feel mild discomfort after large meals. Others experience daily pain severe enough to interfere with work and sleep.
Mild, Moderate, and Severe Cases
Gastroparesis exists on a spectrum, and not everyone with the diagnosis is severely ill. Clinicians generally think of it in three tiers.
Grade 1 (mild) means symptoms are relatively easy to manage. You can maintain your weight and get adequate nutrition from a regular diet, possibly with minor adjustments like eating smaller, more frequent meals or avoiding high-fat and high-fiber foods that slow digestion further.
Grade 2 (compensated) involves more persistent symptoms that need medication to partially control. You can still eat enough to maintain nutrition, but it requires deliberate dietary and lifestyle changes. Hospital visits are rare at this stage.
Grade 3 (severe, sometimes called gastric failure) is the most debilitating form. Symptoms don’t respond adequately to medications, oral nutrition becomes difficult or impossible, and frequent emergency room visits or hospitalizations are common. Some patients at this stage require feeding tubes or other interventions to get enough calories.
Most people with gastroparesis fall into the mild or moderate categories. The severe form gets the most attention online because those patients are the most vocal about their experiences, which can skew the perception of what living with gastroparesis typically looks like.
Is It Becoming More Common?
There are reasons to think the number of diagnosed cases is rising, though separating genuine increases from better detection is difficult. Awareness of gastroparesis among both patients and doctors has grown significantly in the past decade. Gastric emptying studies are ordered more frequently than they used to be. At the same time, rising rates of diabetes worldwide feed directly into the pipeline of diabetic gastroparesis cases, and post-COVID complications appear to be adding new idiopathic cases to the count.
Whether gastroparesis will eventually lose its “rare” designation depends partly on how well diagnostic standards are applied. Given that 80% of referrals at one major center turned out to be something else, better testing could simultaneously increase the number of true diagnoses while removing incorrect ones, making the real prevalence clearer than it’s ever been.

